Engineered dendritic cells from cord blood and adult blood accelerate effector T cell immune reconstitution against HCMV.
Name:
Daenthanasanmak et al_final.pdf
Size:
3.500Mb
Format:
PDF
Description:
Open Access publication
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Daenthanasanmak, AnusaraSalguero, Gustavo
Sundarasetty, Bala Sai
Waskow, Claudia
Cosgun, Kadriye Nehir
Guzman, Carlos A
Riese, Peggy
Gerasch, Laura
Schneider, Andreas
Ingendoh, Alexandra
Messerle, Martin
Gabaev, Ildar
Woelk, Benno
Ruggiero, Eliana
Schmidt, Manfred
von Kalle, Christof
Figueiredo, Constanca
Eiz-Vesper, Britta
von Kaisenberg, Constantin
Ganser, Arnold
Stripecke, Renata
Issue Date
2015
Metadata
Show full item recordAbstract
Human cytomegalovirus (HCMV) harmfully impacts survival after peripheral blood hematopoietic stem cell transplantation (PB-HSCT). Delayed immune reconstitution after cord blood (CB)-HSCT leads to even higher HCMV-related morbidity and mortality. Towards a feasible dendritic cell therapy to accelerate de novo immunity against HCMV, we validated a tricistronic integrase-defective lentiviral vector (coexpressing GM-CSF, IFN-α, and HCMV pp65 antigen) capable to directly induce self-differentiation of PB and CB monocytes into dendritic cells processing pp65 ("SmyleDCpp65"). In vitro, SmyleDCpp65 resisted HCMV infection, activated CD4(+) and CD8(+) T cells and expanded functional pp65-specific memory cytotoxic T lymphocytes (CTLs). CD34(+) cells obtained from PB and CB were transplanted into irradiated NOD.Rag1(-/-).IL2γc(-/-) mice. Donor-derived SmyleDCpp65 administration after PB-HSCT stimulated peripheral immune effects: lymph node remodeling, expansion of polyclonal effector memory CD8(+) T cells in blood, spleen and bone marrow, and pp65-reactive CTL and IgG responses. SmyleDCpp65 administration after CB-HSCT significantly stimulated thymopoiesis. Expanded frequencies of CD4(+)/CD8(+) T cell precursors containing increased levels of T-cell receptor excision circles in thymus correlated with peripheral expansion of effector memory CTL responses against pp65. The comparative in vivo modeling for PB and CB-HSCT provided dynamic and spatial information regarding human T and B cell reconstitution. In vivo potency supports future clinical development of SmyleDCpp65.Citation
Engineered dendritic cells from cord blood and adult blood accelerate effector T cell immune reconstitution against HCMV. 2015, 1:14060 Mol Ther Methods Clin DevAffiliation
Helmholtz Centre for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, Germany.PubMed ID
26052526Type
ArticleLanguage
enISSN
2329-0501ae974a485f413a2113503eed53cd6c53
10.1038/mtm.2014.60
Scopus Count
The following license files are associated with this item: